VAIM Demonstrates JUVELOOK's Competitive Edge at JP Morgan Conference Two-session presentations draw recognition from global industry professionals
VAIM was invited as the only Korean company to speak at two sessions of the JP Morgan Healthcare Conference, the world's largest healthcare investment symposium, showcasing the technological prowess of K-medical aesthetics. At the event held in San Francisco from January 12-15, co-CEOs Jonghyeon Park and Donghoon Jeon presented VAIM's flagship product JUVELOOK and mid- to long-term growth strategy at the Beyond K-Beauty session and Investor Presentation session. CEO Jeon emphasized JUVELOOK's differentiated technology, stating that "the Korean beauty industry is leading the global trend toward natural beauty." Since its 2019 launch, JUVELOOK has surpassed 2 million vials in cumulative production and is expanding into 72 countries worldwide. VAIM announced that it will continue to strengthen its position in the global medical aesthetics market based on its proven technological competitiveness.
#MedicalAestheticNews #VAIM #JUVELOOK #LENISNA
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11147

Comments
Post a Comment